优化突发性耳聋的高压氧治疗方案
这项多中心回顾性队列研究纳入1309例符合2019 AAO-HNS指南的突发性感音神经性聋患者,比较高压氧联合皮质类固醇组(n=991)与单用皮质类固醇组(n=318)的听力恢复情况。结果显示11至20次高压氧治疗显著提高治疗结束时轻度恢复和部分恢复率,并在90天时促进完全恢复,疗效受初始听力损失程度等因素影响。
要点
- 11至20次高压氧治疗可提高治疗结束时轻度与部分恢复率,但不提高完全恢复率。
- 90天随访时11至20次高压氧治疗显著促进完全恢复。
- 建议发病两周内尽早开始10至20次高压氧治疗,尤其适用于重度及全聋患者。
核心结论
- 高压氧联合皮质类固醇可改善突发性感音神经性聋患者的听力恢复。
研究设计与样本
- 多中心回顾性队列研究,纳入1309例符合2019 AAO-HNS指南的患者,来自上海4家配备高压氧设施的 tertiary hospitals,入组时间为2022年1月至2024年9月。
- 高压氧组(n=991)接受2.2 ATA高压氧联合皮质类固醇治疗,非高压氧组(n=318)单用皮质类固醇。
主要发现
- 11至20次高压氧治疗显著提高治疗结束时轻度恢复率(OR=2.205,95%CI:1.399-3.474,P=.001)和部分恢复率(OR=2.236,95%CI:1.429-3.500,P<.001),但不提高完全恢复率。
- 90天随访时,11至20次高压氧治疗显著促进完全恢复(OR=0.422,95%CI:0.224-0.793,P=.007)。
- 疗效受初始听力损失程度显著影响,全聋患者部分恢复率低于较轻损失者,而极重度聋患者部分恢复率最高(125.3%)。
- 年龄、延迟治疗、眩晕和高初始纯音阈值是独立预后因素(P<.05)。
- 未发生严重不良事件。
关键数值与推荐
- 推荐早期开始10至20次高压氧治疗,最好在发病两周内,尤其适用于重度及全聋患者。
临床怎么用
- 临床可考虑对突发性感音神经性聋患者在发病两周内尽早启动10至20次高压氧联合皮质类固醇治疗。
- 应关注年龄、延迟治疗、眩晕和高初始纯音阈值等独立预后因素。
- 未来研究应标准化疗效判定标准以推进个体化治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To optimize the hyperbaric oxygen therapy protocol for sudden sensorineural hearing loss by identifying the most effective treatment course and analyzing key prognostic factors through a multicenter retrospective cohort study. STUDY DESIGN: Retrospective cohort study. SETTING: The study conducted at 4 tertiary hospitals equipped with hyperbaric oxygen (HBO) facilities in Shanghai, China. Patient enrollment occurred between January 2022 and September 2024. Participants were identified from the clinical records of patients presenting with sudden sensorineural hearing loss (SSNHL) at the participating centers. METHODS: This multicenter retrospective cohort study (n = 1309) enrolled patients meeting 2019 AAO-HNS guidelines. The HBO group (n = 991) received 2.2 ATA HBO combined with corticosteroids, while the non-HBO group (n = 318) received corticosteroids alone. Primary and secondary outcomes were hearing recovery rates at treatment completion and 90-day follow-up, respectively. RESULTS: 11 to 20 HBO sessions significantly increased rates of slight (OR = 2.205, 95% CI: 1.399-3.474, P = .001) and partial recovery (OR = 2.236, 95% CI: 1.429-3.500, P < .001) at treatment completion, but not complete recovery. At 90 days, 11 to 20 sessions significantly promoted complete recovery (OR = 0.422, 95% CI: 0.224-0.793, P = .007). Efficacy was significantly influenced by initial hearing loss degree; patients with total deafness showed lower partial recovery rates versus those with milder losses, while patients with very severe deafness showed the highest (125.3%). Age, delayed treatment, vertigo, and high initial pure-tone threshold were independent prognostic factors (P < .05). No serious adverse events occurred. CONCLUSION: HBO combined with corticosteroids improves hearing recovery in SSNHL. Initiating 10 to 20 HBO sessions early, preferably within two weeks of onset, is recommended, especially for severe and total deafness. Future studies should standardize efficacy criteria to advance individualized treatment.
引用
- Sun Y, Yang Y, Wang Z, et al. Optimizing Hyperbaric Oxygen Therapy for Sudden Hearing Loss. Otolaryngol Head Neck Surg. 2026. PMID: 42820475. doi:10.1002/ohn.70449
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。